Xiangrui Jiang

4 ta ish

State Key Laboratory of Drug Research, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

1. Repurposing of Rutan showed effective treatment for COVID-19 disease

   Shavkat Salikhov, Ibrokhim Y. Abdurakhmonov, Yuliya I. Oshchepkova +15

   MaqolaDiverse Scientific Research StudiesFrontiers in Medicine20236 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.000825

2. Repurposing of Rutan showed effective treatment for COVID-19 disease

   Shavkat Salikhov, Ibrokhim Y. Abdurakhmonov, Jamolitdin F. Ziyavitdinov +15

   PreprintMedicinal Plant ResearchResearch Square20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.preprint.000050

3. Repurposing of Rutan showed effective treatment for COVID-19 disease

   Shavkat Salikhov, Ibrokhim Y. Abdurakhmonov, Jamolitdin F. Ziyavitdinov +15

   PreprintMedicinal Plant ResearchResearch Square20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.preprint.000109

4. Asymmetric Total Synthesis and Anti-Inflammatory Activity of Berbamine, Oxyacanthine, and Related Intermediates

   Li Xiang, Jishan Qin, Temur A. Kushatov +7

   MaqolaBerberine and alkaloids researchJournal of Natural Products20250 iqtibos

   ABIABI:AkademIndex/openalex/2025.article.010624